88
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital

&
Pages 563-567 | Published online: 04 Nov 2015

References

  • MuralidharanAWhiteSThe need for kidney transplantation in low-and middle-income countries in 2012: an epidemiological perspectiveTransplantation201599347648125680089
  • IngsathitAThakkinstianAChaiprasertAPrevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK studyNephrol Dial Transplant20102551567157520037182
  • SchiffrinELLipmanMLMannJFChronic kidney disease: effects on the cardiovascular systemCirculation20071161859717606856
  • GoASChertowGMFanDMcCullochCEHsuCYChronic kidney disease and the risks of death, cardiovascular events, and hospitalizationN Engl J Med2004351131296130515385656
  • KanbayMTurgutFCovicAGoldsmithDStatin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidenceJ Nephrol200922559860919809992
  • National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in AThird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
  • European Association for Cardiovascular Prevention and RehabilitationReinerZCatapanoALESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
  • StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 Suppl 2S1S4524222016
  • BellostaSPaolettiRCorsiniASafety of statins: focus on clinical pharmacokinetics and drug interactionsCirculation200410923 Suppl 1III50III5715198967
  • StoneNJBilekSRosenbaumSRecent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and optionsAm J Cardiol2005964A53E59E
  • BaigentCLandrayMJReithCThe effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialLancet201137797842181219221663949
  • WatersDDLDL-cholesterol lowering and renal outcomesCurr Opin Lipidol201526319519925887677
  • TonelliMWannerCKidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group MembersLipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guidelineAnn Intern Med2014160318224323134